A magnetization transfer histogram study of normal-appearing brain tissue in MS

Neurology

Volumn 54, Issue 1, 2000, Pages 186-193

  Tortorella, C ^a   Viti, B ^a   Bozzali, M ^a   Sormani, M P ^a,d   Rizzo, G ^c   Gilardi, M F ^c   Comi, G ^b   Filippi, Massimo ^a,c  

^a Neuroimaging Research Unit   (Italy)

^b Metabolic and Cardiovascular Division   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Magnetization transfer imaging; MRI; MS; Normal appearing brain tissue

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL;

EID: 0033981062     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.1.186     Document Type: Article

References (60)

1. Arstila AU, Riekkinen P, Rinne UK, Laitinen L. Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques. Eur Neurol 1973;9:1-20.
2. Adams CMW. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 1977;33:15-20.
3. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81-91.
4. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285.
5. Evangelou N, Esiri M, Palace J, Matthews PM. A quantitative pathological study of axonal loss in the corpus callosum in multiple sclerosis. Mult Scler 1998;4:287. Abstract.
6. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16.
7. Filippi M. The role of non-conventional magnetic resonance techniques in monitoring the evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64(suppl 1):2-58.
8. Filippi M, Horsefield MA, Adèr HJ, et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 1998;43:449-506.
9. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992; 18:319-334.
10. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-274.
11. Brück W, Bitsch A, Kolenda H, Brück Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-793.
12. 1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-1288.
13. Kidd D, Barker GJ, Tofts PS, et al. The transverse magnetization decay characteristics of longstanding lesions and normal appearing white matter in multiple sclerosis. J Neurol 1997; 244:125-130.
14. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann Neurol 1994;36:62-67.
15. Davie CA, Barker GJ, Thompson AJ, Tofts PS, McDonald WI, Miller DH. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesion and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:736-742.
16. 1-weighted) spin-echo images. Neurology 1995;45:1684-1690.
17. 1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476.
18. Filippi M, Iannucci G, Tortorella C, et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999;52:588-594.
19. Fu L, Matthews PM, De Stefano N, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998;121:103-113.
20. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-482.
21. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511-515.
22. van Buchem MA, Grossman RI, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609-1617.
23. Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601-1608.
24. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636.
25. Phillips MD, Grossman RI, Miki Y, et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measure of lesion burden in patients with multiple sclerosis. AJNR Am J Neuroradiol 1998; 19:1055-1060.
26. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1993;13:227-231.
27. Lublin FD, Reingold SC, the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911.
28. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
29. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-688.
30. Grimaud J, Lai M, Thorpe JW, et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996;14: 495-505.
31. 2-weighted images. J Neurol 1997;244:266-270.
32. Losseff NA, Wang L, Lai HM, et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 1996;119: 2009-2019.
33. Robb, RA, Hanson DP, Karwoski RA, Larson AG, Workman EL, Stacy MC. Analyze: a comprehensive operator-interactive software package for multi-dimensional medical image display and analysis. Comp Med Imaging Graphic 1989;13:433-454.
34. Jiang H, Robb R, Holton KS. A new approach to 3-D registration of multimodality medical images by surface matching. Proc SPIE 1992;1808:196-213.
35. West J, Fitzpatrick JM, Wang MY, et al. Comparison and evaluation of retrospective intermodality brain image registration techniques. J Comput Assist Tomogr 1997;21:554-566.
36. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62.
37. Lycklama á Nijeholt GJ, van Walderveen MAA, Castelijins JA, et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687-697.
38. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809-814.
39. Goodkin DE, Rooney WD, Sloan R, et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 1998;51:1689-1697.
40. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491.
41. Filippi M, Yousry TA, Baratti C, et al. Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain 1996;119:1349-1355.
42. Gawne-Cain ML, O'Riordan JI, Thompson AJ, Moseley IF, Miller DH. Multiple sclerosis lesion detection in the brain: a comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin-echo. Neurology 1997;49: 364-370.
43. Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H. Symptoms and signs of multiple sclerosis. Mc-Alpine's multiple sclerosis. London: Churchill Livingstone, 1998.
44. Grimaud J, Millar J, Thorpe JW, Moseley IF, McDonald WI, Miller DH. Signal intensity on MRI of basal ganglia in multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;59:306-308.
45. Metha RC, Pike B, Enzmann DR. Magnetization transfer MR of the normal adult brain. AJNR Am J Neuroradiol 1995;16: 2085-2091.
46. Vavasour IM, Whittall KP, MacKay A, Li DBK, Vorobeychik G, Paty DW. A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients. Magn Reson Med 1998;40:763-768.
47. Lundbom N. Determination of magnetization transfer contrast in tissue: an MR imaging study of brain tumors. AJR Am J Roentgenol 1992;159:1279-1285.
48. Barbosa S, Blumhardt LD, Roberts N, Lock T, Edwards RH. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. Magn Reson Imaging 1994;12:33-42.
49. Filippi M, Yousry T, Horsfield MA, et al. A high-resolution three dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann Neurol 1996;40:901-907.
50. Filippi M, Horsfield MA, Campi A, Mammi S, Pereira C, Comi G. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 1995;38:749-754.
51. Filippi M, Rocca MA, Horsfield MA, et al. Increased spatial resolution using a three-dimensional T1-weighted gradient-echo MR sequence results in greater hypointense lesion volumes in multiple sclerosis. AJNR Am J Neuroradiol 1998;19: 235-238.
52. Keiper MD, Grossman RI, Hirsch JA, et al. MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. AJNR Am J Neuroradiol 1998;19: 1489-1493.
53. Leary SM, Silver NC, Stevenson VL, Miller DH, Thompson AJ. Magnetization transfer ratio of normal appearing white matter in primary progressive multiple sclerosis. Mult Scler 1998;4:297. Abstract.
54. Filippi M, Barker GJ, Horsfield MA, et al. Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study. J Neurol 1994;241:246-251.
55. Filippi M, Campi A, Martinelli V, Colombo B, Scotti G, Comi G. Brain and spinal cord MR in benign multiple sclerosis: a follow-up study. J Neurol Sci 1996;143:143-149.
56. Falini A, Calabrese G, Filippi M, et al. Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. AJNR Am J Neuroradiol 1998;19:223-229.
57. Filippi M, Mastronardo G, Rocca MA, Pereira C, Comi G. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis. J Neurol Sci 1998;158:148-153.
58. De Stefano N, Matthews PM, Narayanan S, Francis GS, Antel JP, Arnold DL. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 1997;49:1138-1141.
59. De Stefano N, Narayanan S, Matthews PM, Francis GS, Antel JP, Arnold DL. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 1999;122:1933-1939.
60. Thompson AJ, Polman CH, Miller DH, et al. Primary progressive multiple sclerosis. Brain 1997;120:1085-1096.